nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—SLCO1B3—Docetaxel—head and neck cancer	0.258	0.299	CbGbCtD
Atazanavir—ABCC1—Vinblastine—head and neck cancer	0.217	0.251	CbGbCtD
Atazanavir—ABCC1—Docetaxel—head and neck cancer	0.179	0.207	CbGbCtD
Atazanavir—CYP2C9—Fluorouracil—head and neck cancer	0.0581	0.0673	CbGbCtD
Atazanavir—ABCB1—Vinblastine—head and neck cancer	0.0523	0.0605	CbGbCtD
Atazanavir—ABCB1—Docetaxel—head and neck cancer	0.0431	0.0499	CbGbCtD
Atazanavir—CYP3A4—Vinblastine—head and neck cancer	0.0313	0.0362	CbGbCtD
Atazanavir—CYP3A4—Docetaxel—head and neck cancer	0.0258	0.0299	CbGbCtD
Atazanavir—Atrophy—Hydroxyurea—head and neck cancer	0.00519	0.0382	CcSEcCtD
Atazanavir—Peptic ulcer—Vinblastine—head and neck cancer	0.00277	0.0204	CcSEcCtD
Atazanavir—Eruption—Hydroxyurea—head and neck cancer	0.00275	0.0202	CcSEcCtD
Atazanavir—Oesophageal ulcer—Docetaxel—head and neck cancer	0.00241	0.0177	CcSEcCtD
Atazanavir—Cellulitis—Vinblastine—head and neck cancer	0.00204	0.015	CcSEcCtD
Atazanavir—Bone pain—Vinblastine—head and neck cancer	0.00194	0.0142	CcSEcCtD
Atazanavir—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00193	0.0142	CcSEcCtD
Atazanavir—Nail disorder—Fluorouracil—head and neck cancer	0.00188	0.0138	CcSEcCtD
Atazanavir—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00154	0.0113	CcSEcCtD
Atazanavir—Eruption—Docetaxel—head and neck cancer	0.00143	0.0105	CcSEcCtD
Atazanavir—Disorientation—Hydroxyurea—head and neck cancer	0.00137	0.0101	CcSEcCtD
Atazanavir—Nail disorder—Docetaxel—head and neck cancer	0.00136	0.00997	CcSEcCtD
Atazanavir—Cellulitis—Fluorouracil—head and neck cancer	0.00134	0.00985	CcSEcCtD
Atazanavir—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00128	0.00945	CcSEcCtD
Atazanavir—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00128	0.0094	CcSEcCtD
Atazanavir—Burning sensation—Docetaxel—head and neck cancer	0.00127	0.00931	CcSEcCtD
Atazanavir—Inflammation—Fluorouracil—head and neck cancer	0.00126	0.00924	CcSEcCtD
Atazanavir—Oesophagitis—Fluorouracil—head and neck cancer	0.00111	0.00819	CcSEcCtD
Atazanavir—Breast disorder—Hydroxyurea—head and neck cancer	0.00111	0.00816	CcSEcCtD
Atazanavir—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00111	0.00814	CcSEcCtD
Atazanavir—Rhinorrhoea—Docetaxel—head and neck cancer	0.00108	0.00798	CcSEcCtD
Atazanavir—Pancreatitis—Hydroxyurea—head and neck cancer	0.00104	0.00766	CcSEcCtD
Atazanavir—Depression—Vinblastine—head and neck cancer	0.00103	0.00761	CcSEcCtD
Atazanavir—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00102	0.00748	CcSEcCtD
Atazanavir—Photosensitivity—Fluorouracil—head and neck cancer	0.00101	0.00741	CcSEcCtD
Atazanavir—Amenorrhoea—Docetaxel—head and neck cancer	0.001	0.00736	CcSEcCtD
Atazanavir—Neutropenia—Hydroxyurea—head and neck cancer	0.000992	0.0073	CcSEcCtD
Atazanavir—Disorientation—Fluorouracil—head and neck cancer	0.000988	0.00727	CcSEcCtD
Atazanavir—Oropharyngeal pain—Docetaxel—head and neck cancer	0.000966	0.00711	CcSEcCtD
Atazanavir—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000966	0.00711	CcSEcCtD
Atazanavir—Weight increased—Hydroxyurea—head and neck cancer	0.000966	0.00711	CcSEcCtD
Atazanavir—Oliguria—Docetaxel—head and neck cancer	0.000954	0.00702	CcSEcCtD
Atazanavir—Drug interaction—Docetaxel—head and neck cancer	0.000947	0.00697	CcSEcCtD
Atazanavir—Amnesia—Fluorouracil—head and neck cancer	0.000941	0.00692	CcSEcCtD
Atazanavir—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000929	0.00684	CcSEcCtD
Atazanavir—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000928	0.00682	CcSEcCtD
Atazanavir—Hypoaesthesia—Vinblastine—head and neck cancer	0.000927	0.00682	CcSEcCtD
Atazanavir—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000925	0.0068	CcSEcCtD
Atazanavir—Stomatitis—Hydroxyurea—head and neck cancer	0.000922	0.00679	CcSEcCtD
Atazanavir—Bone pain—Docetaxel—head and neck cancer	0.000917	0.00675	CcSEcCtD
Atazanavir—Inflammation—Docetaxel—head and neck cancer	0.000906	0.00667	CcSEcCtD
Atazanavir—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000895	0.00658	CcSEcCtD
Atazanavir—Hepatocellular injury—Docetaxel—head and neck cancer	0.000879	0.00647	CcSEcCtD
Atazanavir—Hallucination—Hydroxyurea—head and neck cancer	0.000845	0.00622	CcSEcCtD
Atazanavir—Colitis—Docetaxel—head and neck cancer	0.000844	0.00621	CcSEcCtD
Atazanavir—Cardiac arrest—Fluorouracil—head and neck cancer	0.00084	0.00618	CcSEcCtD
Atazanavir—Fluid retention—Docetaxel—head and neck cancer	0.000834	0.00614	CcSEcCtD
Atazanavir—Alopecia—Vinblastine—head and neck cancer	0.000823	0.00606	CcSEcCtD
Atazanavir—Dry skin—Fluorouracil—head and neck cancer	0.00081	0.00596	CcSEcCtD
Atazanavir—Oesophagitis—Docetaxel—head and neck cancer	0.000803	0.00591	CcSEcCtD
Atazanavir—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00079	0.00582	CcSEcCtD
Atazanavir—Muscular weakness—Fluorouracil—head and neck cancer	0.00078	0.00574	CcSEcCtD
Atazanavir—Angiopathy—Hydroxyurea—head and neck cancer	0.000771	0.00567	CcSEcCtD
Atazanavir—Eosinophilia—Fluorouracil—head and neck cancer	0.000756	0.00556	CcSEcCtD
Atazanavir—Ill-defined disorder—Vinblastine—head and neck cancer	0.000752	0.00554	CcSEcCtD
Atazanavir—Alopecia—Hydroxyurea—head and neck cancer	0.000751	0.00552	CcSEcCtD
Atazanavir—Malaise—Vinblastine—head and neck cancer	0.000731	0.00538	CcSEcCtD
Atazanavir—Convulsion—Vinblastine—head and neck cancer	0.000703	0.00517	CcSEcCtD
Atazanavir—Hypertension—Vinblastine—head and neck cancer	0.0007	0.00515	CcSEcCtD
Atazanavir—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000697	0.00513	CcSEcCtD
Atazanavir—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000686	0.00505	CcSEcCtD
Atazanavir—Discomfort—Vinblastine—head and neck cancer	0.000682	0.00502	CcSEcCtD
Atazanavir—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000668	0.00491	CcSEcCtD
Atazanavir—Dermatitis bullous—Docetaxel—head and neck cancer	0.000668	0.00491	CcSEcCtD
Atazanavir—Malaise—Hydroxyurea—head and neck cancer	0.000667	0.00491	CcSEcCtD
Atazanavir—Stomatitis—Fluorouracil—head and neck cancer	0.000664	0.00488	CcSEcCtD
Atazanavir—Urinary tract infection—Fluorouracil—head and neck cancer	0.000662	0.00487	CcSEcCtD
Atazanavir—Convulsion—Hydroxyurea—head and neck cancer	0.000641	0.00471	CcSEcCtD
Atazanavir—Pain in extremity—Docetaxel—head and neck cancer	0.000638	0.00469	CcSEcCtD
Atazanavir—Anorexia—Vinblastine—head and neck cancer	0.000631	0.00464	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000625	0.0046	CcSEcCtD
Atazanavir—Discomfort—Hydroxyurea—head and neck cancer	0.000622	0.00458	CcSEcCtD
Atazanavir—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000608	0.00448	CcSEcCtD
Atazanavir—Oedema—Hydroxyurea—head and neck cancer	0.000604	0.00444	CcSEcCtD
Atazanavir—Infection—Hydroxyurea—head and neck cancer	0.0006	0.00441	CcSEcCtD
Atazanavir—Dehydration—Docetaxel—head and neck cancer	0.000593	0.00437	CcSEcCtD
Atazanavir—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000592	0.00435	CcSEcCtD
Atazanavir—Skin disorder—Hydroxyurea—head and neck cancer	0.000586	0.00431	CcSEcCtD
Atazanavir—Dry skin—Docetaxel—head and neck cancer	0.000585	0.0043	CcSEcCtD
Atazanavir—Breast disorder—Docetaxel—head and neck cancer	0.000577	0.00424	CcSEcCtD
Atazanavir—Anorexia—Hydroxyurea—head and neck cancer	0.000575	0.00423	CcSEcCtD
Atazanavir—Decreased appetite—Vinblastine—head and neck cancer	0.000575	0.00423	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000574	0.00423	CcSEcCtD
Atazanavir—Nasopharyngitis—Docetaxel—head and neck cancer	0.00057	0.0042	CcSEcCtD
Atazanavir—Constipation—Vinblastine—head and neck cancer	0.000566	0.00416	CcSEcCtD
Atazanavir—Pain—Vinblastine—head and neck cancer	0.000566	0.00416	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000563	0.00414	CcSEcCtD
Atazanavir—Feeling abnormal—Vinblastine—head and neck cancer	0.000545	0.00401	CcSEcCtD
Atazanavir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000541	0.00398	CcSEcCtD
Atazanavir—Alopecia—Fluorouracil—head and neck cancer	0.00054	0.00398	CcSEcCtD
Atazanavir—Dyspnoea—Hydroxyurea—head and neck cancer	0.000538	0.00396	CcSEcCtD
Atazanavir—Somnolence—Hydroxyurea—head and neck cancer	0.000537	0.00395	CcSEcCtD
Atazanavir—Dyspepsia—Hydroxyurea—head and neck cancer	0.000531	0.00391	CcSEcCtD
Atazanavir—Decreased appetite—Hydroxyurea—head and neck cancer	0.000525	0.00386	CcSEcCtD
Atazanavir—Abdominal pain—Vinblastine—head and neck cancer	0.000523	0.00385	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000521	0.00383	CcSEcCtD
Atazanavir—Fatigue—Hydroxyurea—head and neck cancer	0.00052	0.00383	CcSEcCtD
Atazanavir—Pain—Hydroxyurea—head and neck cancer	0.000516	0.0038	CcSEcCtD
Atazanavir—Constipation—Hydroxyurea—head and neck cancer	0.000516	0.0038	CcSEcCtD
Atazanavir—Neutropenia—Docetaxel—head and neck cancer	0.000516	0.00379	CcSEcCtD
Atazanavir—Weight increased—Docetaxel—head and neck cancer	0.000502	0.00369	CcSEcCtD
Atazanavir—Weight decreased—Docetaxel—head and neck cancer	0.000499	0.00367	CcSEcCtD
Atazanavir—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000497	0.00366	CcSEcCtD
Atazanavir—Hypersensitivity—Vinblastine—head and neck cancer	0.000488	0.00359	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000487	0.00359	CcSEcCtD
Atazanavir—Renal failure—Docetaxel—head and neck cancer	0.000483	0.00356	CcSEcCtD
Atazanavir—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000482	0.00355	CcSEcCtD
Atazanavir—Stomatitis—Docetaxel—head and neck cancer	0.000479	0.00353	CcSEcCtD
Atazanavir—Jaundice—Docetaxel—head and neck cancer	0.000479	0.00353	CcSEcCtD
Atazanavir—Body temperature increased—Hydroxyurea—head and neck cancer	0.000477	0.00351	CcSEcCtD
Atazanavir—Asthenia—Vinblastine—head and neck cancer	0.000475	0.00349	CcSEcCtD
Atazanavir—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000465	0.00342	CcSEcCtD
Atazanavir—Convulsion—Fluorouracil—head and neck cancer	0.000461	0.00339	CcSEcCtD
Atazanavir—Myalgia—Fluorouracil—head and neck cancer	0.000453	0.00333	CcSEcCtD
Atazanavir—Chest pain—Fluorouracil—head and neck cancer	0.000453	0.00333	CcSEcCtD
Atazanavir—Diarrhoea—Vinblastine—head and neck cancer	0.000453	0.00333	CcSEcCtD
Atazanavir—Discomfort—Fluorouracil—head and neck cancer	0.000448	0.00329	CcSEcCtD
Atazanavir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000445	0.00327	CcSEcCtD
Atazanavir—Hepatitis—Docetaxel—head and neck cancer	0.000441	0.00325	CcSEcCtD
Atazanavir—Hypoaesthesia—Docetaxel—head and neck cancer	0.000439	0.00323	CcSEcCtD
Atazanavir—Confusional state—Fluorouracil—head and neck cancer	0.000438	0.00322	CcSEcCtD
Atazanavir—Dizziness—Vinblastine—head and neck cancer	0.000438	0.00322	CcSEcCtD
Atazanavir—Urinary tract disorder—Docetaxel—head and neck cancer	0.000436	0.00321	CcSEcCtD
Atazanavir—Oedema peripheral—Docetaxel—head and neck cancer	0.000435	0.0032	CcSEcCtD
Atazanavir—Oedema—Fluorouracil—head and neck cancer	0.000434	0.0032	CcSEcCtD
Atazanavir—Connective tissue disorder—Docetaxel—head and neck cancer	0.000434	0.00319	CcSEcCtD
Atazanavir—Asthenia—Hydroxyurea—head and neck cancer	0.000433	0.00319	CcSEcCtD
Atazanavir—Urethral disorder—Docetaxel—head and neck cancer	0.000433	0.00318	CcSEcCtD
Atazanavir—Infection—Fluorouracil—head and neck cancer	0.000432	0.00318	CcSEcCtD
Atazanavir—Nervous system disorder—Fluorouracil—head and neck cancer	0.000426	0.00313	CcSEcCtD
Atazanavir—Vomiting—Vinblastine—head and neck cancer	0.000421	0.0031	CcSEcCtD
Atazanavir—Erythema multiforme—Docetaxel—head and neck cancer	0.000417	0.00307	CcSEcCtD
Atazanavir—Headache—Vinblastine—head and neck cancer	0.000415	0.00305	CcSEcCtD
Atazanavir—Anorexia—Fluorouracil—head and neck cancer	0.000414	0.00305	CcSEcCtD
Atazanavir—Diarrhoea—Hydroxyurea—head and neck cancer	0.000413	0.00304	CcSEcCtD
Atazanavir—Eye disorder—Docetaxel—head and neck cancer	0.000412	0.00303	CcSEcCtD
Atazanavir—Cardiac disorder—Docetaxel—head and neck cancer	0.00041	0.00301	CcSEcCtD
Atazanavir—Angiopathy—Docetaxel—head and neck cancer	0.0004	0.00295	CcSEcCtD
Atazanavir—Dizziness—Hydroxyurea—head and neck cancer	0.000399	0.00294	CcSEcCtD
Atazanavir—Immune system disorder—Docetaxel—head and neck cancer	0.000399	0.00293	CcSEcCtD
Atazanavir—Mediastinal disorder—Docetaxel—head and neck cancer	0.000398	0.00293	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000396	0.00291	CcSEcCtD
Atazanavir—Nausea—Vinblastine—head and neck cancer	0.000393	0.00289	CcSEcCtD
Atazanavir—Insomnia—Fluorouracil—head and neck cancer	0.000393	0.00289	CcSEcCtD
Atazanavir—Alopecia—Docetaxel—head and neck cancer	0.00039	0.00287	CcSEcCtD
Atazanavir—Dyspnoea—Fluorouracil—head and neck cancer	0.000387	0.00285	CcSEcCtD
Atazanavir—Mental disorder—Docetaxel—head and neck cancer	0.000387	0.00284	CcSEcCtD
Atazanavir—Somnolence—Fluorouracil—head and neck cancer	0.000386	0.00284	CcSEcCtD
Atazanavir—Malnutrition—Docetaxel—head and neck cancer	0.000384	0.00283	CcSEcCtD
Atazanavir—Vomiting—Hydroxyurea—head and neck cancer	0.000384	0.00282	CcSEcCtD
Atazanavir—Dyspepsia—Fluorouracil—head and neck cancer	0.000382	0.00281	CcSEcCtD
Atazanavir—Rash—Hydroxyurea—head and neck cancer	0.000381	0.0028	CcSEcCtD
Atazanavir—Dermatitis—Hydroxyurea—head and neck cancer	0.00038	0.0028	CcSEcCtD
Atazanavir—Headache—Hydroxyurea—head and neck cancer	0.000378	0.00278	CcSEcCtD
Atazanavir—Decreased appetite—Fluorouracil—head and neck cancer	0.000378	0.00278	CcSEcCtD
Atazanavir—Dysgeusia—Docetaxel—head and neck cancer	0.000376	0.00277	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000375	0.00276	CcSEcCtD
Atazanavir—Back pain—Docetaxel—head and neck cancer	0.000372	0.00273	CcSEcCtD
Atazanavir—Pain—Fluorouracil—head and neck cancer	0.000372	0.00273	CcSEcCtD
Atazanavir—Nausea—Hydroxyurea—head and neck cancer	0.000359	0.00264	CcSEcCtD
Atazanavir—Feeling abnormal—Fluorouracil—head and neck cancer	0.000358	0.00263	CcSEcCtD
Atazanavir—Urticaria—Fluorouracil—head and neck cancer	0.000345	0.00254	CcSEcCtD
Atazanavir—Syncope—Docetaxel—head and neck cancer	0.000345	0.00253	CcSEcCtD
Atazanavir—Body temperature increased—Fluorouracil—head and neck cancer	0.000343	0.00253	CcSEcCtD
Atazanavir—Palpitations—Docetaxel—head and neck cancer	0.00034	0.0025	CcSEcCtD
Atazanavir—Loss of consciousness—Docetaxel—head and neck cancer	0.000338	0.00248	CcSEcCtD
Atazanavir—Cough—Docetaxel—head and neck cancer	0.000335	0.00247	CcSEcCtD
Atazanavir—Convulsion—Docetaxel—head and neck cancer	0.000333	0.00245	CcSEcCtD
Atazanavir—Hypertension—Docetaxel—head and neck cancer	0.000332	0.00244	CcSEcCtD
Atazanavir—Arthralgia—Docetaxel—head and neck cancer	0.000327	0.00241	CcSEcCtD
Atazanavir—Chest pain—Docetaxel—head and neck cancer	0.000327	0.00241	CcSEcCtD
Atazanavir—Myalgia—Docetaxel—head and neck cancer	0.000327	0.00241	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000325	0.00239	CcSEcCtD
Atazanavir—Hypersensitivity—Fluorouracil—head and neck cancer	0.00032	0.00235	CcSEcCtD
Atazanavir—Dry mouth—Docetaxel—head and neck cancer	0.00032	0.00235	CcSEcCtD
Atazanavir—Confusional state—Docetaxel—head and neck cancer	0.000316	0.00233	CcSEcCtD
Atazanavir—Oedema—Docetaxel—head and neck cancer	0.000314	0.00231	CcSEcCtD
Atazanavir—Infection—Docetaxel—head and neck cancer	0.000312	0.00229	CcSEcCtD
Atazanavir—Shock—Docetaxel—head and neck cancer	0.000308	0.00227	CcSEcCtD
Atazanavir—Nervous system disorder—Docetaxel—head and neck cancer	0.000308	0.00226	CcSEcCtD
Atazanavir—Pruritus—Fluorouracil—head and neck cancer	0.000307	0.00226	CcSEcCtD
Atazanavir—Skin disorder—Docetaxel—head and neck cancer	0.000305	0.00224	CcSEcCtD
Atazanavir—Anorexia—Docetaxel—head and neck cancer	0.000299	0.0022	CcSEcCtD
Atazanavir—Diarrhoea—Fluorouracil—head and neck cancer	0.000297	0.00219	CcSEcCtD
Atazanavir—Dizziness—Fluorouracil—head and neck cancer	0.000287	0.00211	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000286	0.0021	CcSEcCtD
Atazanavir—Insomnia—Docetaxel—head and neck cancer	0.000284	0.00209	CcSEcCtD
Atazanavir—Dyspnoea—Docetaxel—head and neck cancer	0.00028	0.00206	CcSEcCtD
Atazanavir—Somnolence—Docetaxel—head and neck cancer	0.000279	0.00205	CcSEcCtD
Atazanavir—Vomiting—Fluorouracil—head and neck cancer	0.000276	0.00203	CcSEcCtD
Atazanavir—Dyspepsia—Docetaxel—head and neck cancer	0.000276	0.00203	CcSEcCtD
Atazanavir—Rash—Fluorouracil—head and neck cancer	0.000274	0.00202	CcSEcCtD
Atazanavir—Dermatitis—Fluorouracil—head and neck cancer	0.000274	0.00201	CcSEcCtD
Atazanavir—Decreased appetite—Docetaxel—head and neck cancer	0.000273	0.00201	CcSEcCtD
Atazanavir—Headache—Fluorouracil—head and neck cancer	0.000272	0.002	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000271	0.00199	CcSEcCtD
Atazanavir—Fatigue—Docetaxel—head and neck cancer	0.00027	0.00199	CcSEcCtD
Atazanavir—Pain—Docetaxel—head and neck cancer	0.000268	0.00197	CcSEcCtD
Atazanavir—Constipation—Docetaxel—head and neck cancer	0.000268	0.00197	CcSEcCtD
Atazanavir—Feeling abnormal—Docetaxel—head and neck cancer	0.000258	0.0019	CcSEcCtD
Atazanavir—Nausea—Fluorouracil—head and neck cancer	0.000258	0.0019	CcSEcCtD
Atazanavir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000256	0.00189	CcSEcCtD
Atazanavir—Abdominal pain—Docetaxel—head and neck cancer	0.000248	0.00182	CcSEcCtD
Atazanavir—Body temperature increased—Docetaxel—head and neck cancer	0.000248	0.00182	CcSEcCtD
Atazanavir—Hypersensitivity—Docetaxel—head and neck cancer	0.000231	0.0017	CcSEcCtD
Atazanavir—Asthenia—Docetaxel—head and neck cancer	0.000225	0.00166	CcSEcCtD
Atazanavir—Pruritus—Docetaxel—head and neck cancer	0.000222	0.00163	CcSEcCtD
Atazanavir—Diarrhoea—Docetaxel—head and neck cancer	0.000215	0.00158	CcSEcCtD
Atazanavir—Dizziness—Docetaxel—head and neck cancer	0.000207	0.00153	CcSEcCtD
Atazanavir—Vomiting—Docetaxel—head and neck cancer	0.000199	0.00147	CcSEcCtD
Atazanavir—Rash—Docetaxel—head and neck cancer	0.000198	0.00145	CcSEcCtD
Atazanavir—Dermatitis—Docetaxel—head and neck cancer	0.000198	0.00145	CcSEcCtD
Atazanavir—Headache—Docetaxel—head and neck cancer	0.000196	0.00145	CcSEcCtD
Atazanavir—Nausea—Docetaxel—head and neck cancer	0.000186	0.00137	CcSEcCtD
